Evogene (TSE:EVGN) Price Target Lowered to C$3.00 at Desjardins
Evogene (TSE:EVGN – Get Free Report) had its price objective decreased by equities researchers at Desjardins from C$4.00 to C$3.00 in a research report issued to clients and investors on Tuesday,BayStreet.CA reports. The brokerage presently has a “buy” rating on the stock. Separately, Ventum Financial cut their price objective on Evogene from C$4.00 to C$3.00 […]
More Stories
Ilhan Omar, Broken Vetting, and Minnesota’s Billion-Dollar Fraud: The Questions That Will Not Die
By Stephen Zogopoulos, USNN World News The federal investigation into Rep. Ilhan Omar’s immigration history and the massive public-benefits fraud...
Democrats Sue Trump Admin Over Bid to Clean Up Voter Rolls
By Zachary Stieber Senate Minority Leader Chuck Schumer (D-N.Y.) and other Democrats have sued the Trump administration over its effort...
Implementing Freight Management Software: In-House or With Specialist Help?
You’ve picked a freight platform. Now you have to get it live without stopping trucks, missing invoices or losing track...
DOGE Illegally Accessed Data on Government Workers: Judge
By Zachary Stieber A federal judge ruled on Oct. 20 that a department aimed at making the government more efficient...
UK Rearrests 2 Men Over Suspected Terror Plot at Air Base
By Jill McLaughlin UK police have rearrested two men, suspected of working for Iran’s intelligence service, for allegedly plotting to...
$245 Million Taxpayer-Backed Loan to Fund Naval Shipbuilding Facilities
By AAP Australia will lend hundreds of millions of dollars to the nation’s largest shipbuilder for a massive new manufacturing...